Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
about
YwdL in Bacillus cereus: its role in germination and exosporium structureAnthrax Toxins in Context of Bacillus anthracis Spores and Spore GerminationPrinciples of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsIdentification of novel and cross-species seroreactive proteins from Bacillus anthracis using a ligation-independent cloning-based, SOS-inducible expression systemAnthrax vaccination strategiesImmunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis AmesLocalization and assembly of proteins comprising the outer structures of the Bacillus anthracis spore.Immunoproteomically identified GBAA_0345, alkyl hydroperoxide reductase subunit C is a potential target for multivalent anthrax vaccine.Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.The Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected HostCharacterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stressIdentification of the UDP-N-acetylglucosamine 4-epimerase involved in exosporium protein glycosylation in Bacillus anthracisProteomic studies of Bacillus anthracis.Anthrax vaccines: present status and future prospects.Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge.
P2860
Q21135252-F1191E56-7760-409D-8060-FC8F9AF23907Q26796601-D6FAB50A-2078-473A-928D-C56D294C1785Q28384852-DD48950A-B21E-4644-A296-38DBBC6E483BQ28388913-C5473749-E069-4BFC-980F-0AA6BFC6B98BQ28392248-44B513A0-52FA-48D0-8315-528FA4CB999AQ28392659-FE0DABCB-C9CB-4268-A8CA-7464C24EB226Q33953761-FB0D0472-62AF-4C3B-A957-6B0BA0CA8653Q35052264-108D83AC-D94B-44C1-91A6-40F089EB794AQ35139395-08759136-4383-4790-AB5D-A332CF887B3CQ36294717-BE601AC4-5CF5-4031-AE92-F5F7A0F072D9Q36523135-3C3F1F00-1976-4C93-9831-E7F3C9E0F302Q37033111-2E0F7BD8-10BC-4E00-A256-BCE61CE2BC73Q37410241-80B7FE3E-D078-4A95-9987-72618FA5066DQ37613667-B2DEFE2C-8948-423E-B2A0-C39D2D4B8EE8Q38132268-C354A840-4CFB-4582-8EBF-C2CA7C2F4FCAQ39143157-0A038DBA-08B8-41D2-8171-74FD5E9EA88CQ44574630-B0E55488-7757-4C2D-A8A2-4D51AB036175
P2860
Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Recombinant Bacillus anthracis ...... amounts of protective antigen.
@en
type
label
Recombinant Bacillus anthracis ...... amounts of protective antigen.
@en
prefLabel
Recombinant Bacillus anthracis ...... amounts of protective antigen.
@en
P2093
P2860
P1433
P1476
Recombinant Bacillus anthracis ...... amounts of protective antigen.
@en
P2093
Alison D O'Brien
Dennis McDaniel
Patrick Sanz
Robert J Cybulski
Robert L Bull
Steve Darnell
P2860
P304
P356
10.1016/J.VACCINE.2008.07.015
P407
P577
2008-07-25T00:00:00Z